Stay updated on Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial page.

Latest updates to the Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe changes are a minor version update in the site footer, adding 'Revision: v3.3.2' and removing 'Revision: v3.2.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedDeletion of the government funding lapse notice from the page is an administrative update that does not affect the study details or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedThe screenshots indicate only layout and formatting updates to the ClinicalTrials.gov record, with no edits to essential study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedMajor change: page now advertises a government operating-status notice and updates the release version to v3.2.0; previous v3.1.0 label was removed.SummaryDifference6%

- Check78 days agoChange DetectedUpdate to versioning information: from Revision v3.0.2 to Revision v3.1.0, with an added identifier 2023908590. No other substantive content changes detected.SummaryDifference0.1%

- Check92 days agoChange DetectedBumps revision from v3.0.1 to v3.0.2. Removes a Back to Top element; no substantive content changes detected.SummaryDifference0.4%

Stay in the know with updates to Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial page.